Experience with Implanon® in a north-east London family planning clinic

European Journal of Contraception and Reproductive Health Care

Volumn 9, Issue 1, 2004, Pages 39-46

  Rai, K ^a   Gupta, S ^a,b   Cotter, S ^b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b Hurst Road Health Centre ^*  (United Kingdom)

Author keywords

Continuation rate; Implanon ; Lifetime

Indexed keywords

ETONOGESTREL; INJECTABLE CONTRACEPTIVE AGENT; 3 KETO DESOGESTREL; 3-KETO-DESOGESTREL; DESOGESTREL;

ADULT; BLEEDING; BREAST TENDERNESS; CONTRACEPTION; COUNSELING; FAMILY PLANNING; FATIGUE; FEMALE; FOLLOW UP; HEADACHE; HUMAN; IMPLANT; KAPLAN MEIER METHOD; LIBIDO DISORDER; MAJOR CLINICAL STUDY; MOOD DISORDER; NULLIPARA; PAIN; PATIENT COMPLIANCE; PILL; PRIORITY JOURNAL; REVIEW; UNITED KINGDOM; WEIGHT GAIN; ARTICLE; OUTPATIENT DEPARTMENT; PATIENT SATISFACTION; PROSTHESES AND ORTHOSES; STATISTICS;

ADULT; AMBULATORY CARE FACILITIES; DESOGESTREL; FEMALE; HEMORRHAGE; HUMANS; LONDON; PATIENT SATISFACTION; PROSTHESES AND IMPLANTS;

EID: 2942531210     PISSN: 13625187     EISSN: None     Source Type: Journal    
DOI: 10.1080/13625180410001696223     Document Type: Review

References (11)

1. Phillips CJ. Economic analysis of long-term and reversible contraceptives: focus on Implanon®. Pharmacoeconomics 2000;17:209-21
2. Edward J, Moore A. Implanon®: a review of clinical studies. J Fam Planning 1999;24:3-16
3. Davie JE, Walling MR, Mansour DJ, et al. Impact of patient counselling on acceptance of the levonorgestrel contraceptive implant in the UK. Clin Ther 1996;18:150-9
4. Glasier A. Implantable contraception for women: effectiveness, discontinuation rates and return of fertility and outcome of pregnancies. Contraception 2002;65:29-37
5. Croxatto H. Clinical profile of Implanon®: a single-rod etonogestrel contraceptive implant. Eur J Contracept Reprod Health Care 2000;5(Suppl 2):21-8
6. Smith A, Reuter S. An assessment of use of Implanon® in 3 community services. Fam Plann Reprod Healthcare 2002;28:193-5
7. Alvarez F, Brache V, Faundes A, et al. Non-menstrual adverse events during use of implantable contraceptives for women: data from clinical trials. Contraception 2002;65:63-74
8. Meirik O, Fraser IS, d'Arcangues C. WHO consultation on implantable contraception for women. Hum Reprod Update 2003;9:1-11
9. Urbancsek J. An integrated analysis of non-menstrual adverse events with Implanon®. Contraception 1998; 58:1095-155
10. International Collaborative Post-marketing Surveillance of Norplant. Post marketing Surveillance of Norplant® contraceptive implants. II. Contraception 2001;63:1157-209
11. Blain S, Lovelady J, Olon E, et al. Reasons for commencing and discontinuing Norplant contraception. Br J Fam Plann 1995;21(Suppl):17-21